TapewireFind a company

organization · Reporting owner

Green Park & Golf Ventures, LLC

Disclosed activity across 1 company

Tapewire entity
143710
SEC CIK
0001598984

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

No relationships currently tracked through insider filings.

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

No balances currently tracked through insider filings.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

Section 16 reporting ended · disclosed 2021-01-19. Current position is not established by this disclosure.

No balance rows disclosed in this filing.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
June 16, 2020 Filed Jun 17, 2020 21:35 UTC Lantern Pharma Inc. LTRN · Entity 7525 ConversionSeries A Preferred Stock, par value $0.01 · Derivative 75,688 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-016898 · doc4.xml · derivative · entry 6

Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner

GPG LPI Investment, LLC · CIK 0001814288 · 10% owner

Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner

Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner

Health Wildcatters, LLC · CIK 0001814291 · 10% owner

Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner

Garcia Gilbert G. II · CIK 0001814289 · 10% owner

Heighten Clay M · CIK 0001599114 · 10% owner

Soderstrom Carl D · CIK 0001598985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 131,697 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_price: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F7 · price: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F7 · derivative.exercise_date: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F7 · derivative.expiration_date: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F4 · derivative.underlying_shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split.

F3 · ownership.nature: These securities are directly held by Lantern 3-19 Investment, LLC ("Lantern 3-19"). Carl D. Soderstrom, Clay M. Heighten, M.D., and Gilbert G. Garcia II are the managing members of Green Park & Golf Ventures II, LLC ("GPG II"), which is the managing member Lantern 3-19. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., Gilbert G. Garcia II, and GPG II may be deemed to beneficially own these securities.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 21:35 UTC Lantern Pharma Inc. LTRN · Entity 7525 ConversionSeries A Preferred Stock, par value $0.01 · Derivative 168,164 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-016898 · doc4.xml · derivative · entry 5

Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner

GPG LPI Investment, LLC · CIK 0001814288 · 10% owner

Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner

Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner

Health Wildcatters, LLC · CIK 0001814291 · 10% owner

Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner

Garcia Gilbert G. II · CIK 0001814289 · 10% owner

Heighten Clay M · CIK 0001599114 · 10% owner

Soderstrom Carl D · CIK 0001598985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 292,605 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_price: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F6 · price: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F6 · derivative.exercise_date: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F6 · derivative.expiration_date: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F4 · derivative.underlying_shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split.

F2 · ownership.nature: These securities are directly held by GPG LPI Investment, LLC ("GPG LPI"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of GPG, which is the managing member GPG LPI. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., and GPG may be deemed to beneficially own these securities.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 21:35 UTC Lantern Pharma Inc. LTRN · Entity 7525 ConversionSeries A Preferred Stock, par value $0.01 · Derivative 23,871 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-016898 · doc4.xml · derivative · entry 4

Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner

GPG LPI Investment, LLC · CIK 0001814288 · 10% owner

Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner

Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner

Health Wildcatters, LLC · CIK 0001814291 · 10% owner

Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner

Garcia Gilbert G. II · CIK 0001814289 · 10% owner

Heighten Clay M · CIK 0001599114 · 10% owner

Soderstrom Carl D · CIK 0001598985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 0

Underlying: Common Stock · 41,535 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_price: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F5 · price: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F5 · derivative.exercise_date: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F5 · derivative.expiration_date: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F4 · derivative.underlying_shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split.

F1 · ownership.nature: These securities are directly held by Health Wildcatters Fund II, LLC ("HWF II"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of Green Park & Golf Ventures, LLC ("GPG"), which is the managing member of Health Wildcatters, LLC ("HW"), which is the managing member of HWF II. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., GPG, and HW may be deemed to beneficially own these securities.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 21:35 UTC Lantern Pharma Inc. LTRN · Entity 7525 ConversionCommon Stock, par value $0.0001 131,697 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-016898 · doc4.xml · nonDerivative · entry 3

Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner

GPG LPI Investment, LLC · CIK 0001814288 · 10% owner

Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner

Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner

Health Wildcatters, LLC · CIK 0001814291 · 10% owner

Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner

Garcia Gilbert G. II · CIK 0001814289 · 10% owner

Heighten Clay M · CIK 0001599114 · 10% owner

Soderstrom Carl D · CIK 0001598985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 131,697

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split.

F7 · price: In connection with the Initial Public Offering, approximately 75,688 shares of Series A Preferred Stock directly held by Lantern 3-19, which had no expiration date, were automatically converted into 131,697 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F3 · ownership.nature: These securities are directly held by Lantern 3-19 Investment, LLC ("Lantern 3-19"). Carl D. Soderstrom, Clay M. Heighten, M.D., and Gilbert G. Garcia II are the managing members of Green Park & Golf Ventures II, LLC ("GPG II"), which is the managing member Lantern 3-19. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., Gilbert G. Garcia II, and GPG II may be deemed to beneficially own these securities.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 21:35 UTC Lantern Pharma Inc. LTRN · Entity 7525 ConversionCommon Stock, par value $0.0001 292,605 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-016898 · doc4.xml · nonDerivative · entry 2

Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner

GPG LPI Investment, LLC · CIK 0001814288 · 10% owner

Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner

Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner

Health Wildcatters, LLC · CIK 0001814291 · 10% owner

Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner

Garcia Gilbert G. II · CIK 0001814289 · 10% owner

Heighten Clay M · CIK 0001599114 · 10% owner

Soderstrom Carl D · CIK 0001598985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 292,605

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split.

F6 · price: In connection with the Initial Public Offering, 168,164 shares of Series A Preferred Stock directly held by GPG LPI, which had no expiration date, were automatically converted into 292,605 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F2 · ownership.nature: These securities are directly held by GPG LPI Investment, LLC ("GPG LPI"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of GPG, which is the managing member GPG LPI. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., and GPG may be deemed to beneficially own these securities.

Read SEC document
June 15, 2020 Filed Jun 17, 2020 21:35 UTC Lantern Pharma Inc. LTRN · Entity 7525 ConversionCommon Stock, par value $0.0001 41,535 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-20-016898 · doc4.xml · nonDerivative · entry 1

Green Park & Golf Ventures II, LLC · CIK 0001782733 · 10% owner

GPG LPI Investment, LLC · CIK 0001814288 · 10% owner

Lantern 3-19 Investment, LLC · CIK 0001814295 · 10% owner

Health Wildcatters Fund II, LLC · CIK 0001814292 · 10% owner

Health Wildcatters, LLC · CIK 0001814291 · 10% owner

Green Park & Golf Ventures, LLC · CIK 0001598984 · 10% owner

Garcia Gilbert G. II · CIK 0001814289 · 10% owner

Heighten Clay M · CIK 0001599114 · 10% owner

Soderstrom Carl D · CIK 0001598985 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 211,291

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · shares: In connection with the Issuer's initial public offering, which commenced on June 10, 2020 and closed on June 15, 2020 (the "Initial Public Offering"), the Issuer effected a 1.74-for-1 stock split on its outstanding common stock, par value $0.0001 (the "Common Stock"), which was made effective immediately prior to the closing of the Issuer's Initial Public Offering (the "Stock Split"). The share amounts set forth in this column reflect the Stock Split.

F5 · price: In connection with the Initial Public Offering, 23,871 shares of the Issuer's Series A Preferred Stock, par value $0.01 ("Series A Preferred Stock"), directly held by HWF II, which had no expiration date, were automatically converted into 41,535 shares of Common Stock for no additional consideration immediately prior to the closing of the Initial Public Offering.

F1 · ownership.nature: These securities are directly held by Health Wildcatters Fund II, LLC ("HWF II"). Carl D. Soderstrom and Clay M. Heighten, M.D. are the managing members of Green Park & Golf Ventures, LLC ("GPG"), which is the managing member of Health Wildcatters, LLC ("HW"), which is the managing member of HWF II. Therefore, Carl D. Soderstrom, Clay M. Heighten, M.D., GPG, and HW may be deemed to beneficially own these securities.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.